CN115725742A - PCR kit for diagnosing psoroptes and detection method - Google Patents
PCR kit for diagnosing psoroptes and detection method Download PDFInfo
- Publication number
- CN115725742A CN115725742A CN202210856989.0A CN202210856989A CN115725742A CN 115725742 A CN115725742 A CN 115725742A CN 202210856989 A CN202210856989 A CN 202210856989A CN 115725742 A CN115725742 A CN 115725742A
- Authority
- CN
- China
- Prior art keywords
- kit
- pcr
- its2
- specific primer
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 32
- 238000009004 PCR Kit Methods 0.000 title claims abstract description 7
- 241001649229 Psoroptes Species 0.000 title description 6
- 101150018198 COX1 gene Chemical group 0.000 claims abstract description 10
- 241000509427 Sarcoptes scabiei Species 0.000 claims description 42
- 238000000137 annealing Methods 0.000 claims description 17
- 238000012408 PCR amplification Methods 0.000 claims description 16
- 108090000623 proteins and genes Proteins 0.000 claims description 15
- 238000004925 denaturation Methods 0.000 claims description 13
- 230000036425 denaturation Effects 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 238000006243 chemical reaction Methods 0.000 claims description 12
- 238000012257 pre-denaturation Methods 0.000 claims description 12
- 201000010099 disease Diseases 0.000 claims description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 10
- 238000007400 DNA extraction Methods 0.000 claims description 7
- 239000003153 chemical reaction reagent Substances 0.000 claims description 6
- 238000003752 polymerase chain reaction Methods 0.000 claims description 4
- 238000001502 gel electrophoresis Methods 0.000 claims description 3
- 238000011144 upstream manufacturing Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 2
- 208000015181 infectious disease Diseases 0.000 abstract description 24
- 241001465754 Metazoa Species 0.000 abstract description 15
- 230000035945 sensitivity Effects 0.000 abstract description 13
- 230000001185 psoriatic effect Effects 0.000 abstract description 10
- 206010000351 Acariasis Diseases 0.000 abstract description 8
- 201000002266 mite infestation Diseases 0.000 abstract description 8
- 230000001823 pruritic effect Effects 0.000 abstract description 5
- 208000030852 Parasitic disease Diseases 0.000 abstract description 3
- 238000007859 qualitative PCR Methods 0.000 abstract description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 26
- 230000003321 amplification Effects 0.000 description 12
- 238000003199 nucleic acid amplification method Methods 0.000 description 12
- 238000003745 diagnosis Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 239000013642 negative control Substances 0.000 description 8
- 238000002965 ELISA Methods 0.000 description 7
- 206010039509 Scab Diseases 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000003550 marker Substances 0.000 description 6
- 229920000742 Cotton Polymers 0.000 description 5
- 241000620639 Psoroptes cervinus Species 0.000 description 5
- 241001649230 Psoroptes ovis Species 0.000 description 5
- 238000002405 diagnostic procedure Methods 0.000 description 5
- 238000007865 diluting Methods 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- 229910021642 ultra pure water Inorganic materials 0.000 description 5
- 239000012498 ultrapure water Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 241000238876 Acari Species 0.000 description 4
- 229920000936 Agarose Polymers 0.000 description 4
- 240000007711 Peperomia pellucida Species 0.000 description 4
- 239000000980 acid dye Substances 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 238000011068 loading method Methods 0.000 description 4
- 238000000386 microscopy Methods 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 102100030878 Cytochrome c oxidase subunit 1 Human genes 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 101000919849 Homo sapiens Cytochrome c oxidase subunit 1 Proteins 0.000 description 3
- 101000605122 Homo sapiens Prostaglandin G/H synthase 1 Proteins 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 208000031504 Asymptomatic Infections Diseases 0.000 description 2
- 208000001840 Dandruff Diseases 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 101150061434 cox gene Proteins 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 210000000613 ear canal Anatomy 0.000 description 2
- 210000005069 ears Anatomy 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 description 1
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- WXOMTJVVIMOXJL-BOBFKVMVSA-A O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@H](O[C@]2(COS(=O)(=O)O[Al](O)O)O[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]2OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O Chemical compound O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@H](O[C@]2(COS(=O)(=O)O[Al](O)O)O[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]2OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O WXOMTJVVIMOXJL-BOBFKVMVSA-A 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 101710107115 Serine protease inhibitor 3 Proteins 0.000 description 1
- 206010040867 Skin hypertrophy Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 244000078703 ectoparasite Species 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229960002418 ivermectin Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003147 molecular marker Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 208000008864 scrapie Diseases 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses an application of ITS2, 16S, 12S and COX1 gene sequences of prurus mite in preparing a kit for diagnosing pruritic acariasis, and in addition, the invention discloses a PCR kit for diagnosing pruritic acariasis, wherein specific primers in the kit can be specifically combined with ITS2, and/or 12S, and/or 16S, and/or COX1 gene sequences of pruritic acarid. The qualitative PCR kit for diagnosing the psoriatic acariasis and the PCR detection method for the psoriatic acariasis by using the kit have higher detection sensitivity than microscopic examination, can discover early infected animals more comprehensively and earlier, have higher sensitivity and specificity, can be used for diagnosing subclinical cases and invisible infected cases with low-load parasitic infection, and can distinguish the existing infection from the emergent infection.
Description
Technical Field
The invention belongs to the technical field of in-vitro diagnosis, and particularly relates to a PCR kit for diagnosing psoroptes and a detection method.
Background
The Psoroptes ovis is a common ectoparasite disease which is popular in the world and is parasitized on the skin surfaces of herbivorous animals and wild animals by Psoroptes ovis, clinically takes pruritus, scabbing, skin thickening and depilation as main clinical symptoms, causes great economic loss to the breeding industry and threatens the survival of the wild animals. The clinical symptoms of visible scab can appear 2 weeks and later after animals are artificially infected with P.ovis once, while the time for the clinical symptoms of visible scab to appear is longer when healthy animals in actual production are infected with P.ovis by contacting affected animals or vectors polluted by mites, and the period can be prolonged to 1 month or even several months.
In the existing production, the diagnostic means of the psoriatic mite is to confirm the diagnosis by observing the mites or mite eggs from scabs through a microscope, the detection rate of severe infection cases is high, but subclinical infection and slight infection cases cannot be detected because scabs are not visible to the naked eye, and the undetected cases become invisible infection sources of the psoriatic mite infection in animal groups, and finally cause the severe epidemic of the psoriatic mite in the animal groups. In addition, the microscopic diagnosis method requires a diagnostician to have a certain professional knowledge of parasites to identify the bodies or eggs, and thus, the microscopic etiology diagnosis method is time-consuming, requires a certain professional knowledge for the operator, and is missing for cases infected with low mite numbers.
In recent years, indirect ELISA diagnostic methods of a plurality of recombinant antigens have been proved to be applicable to the diagnosis of the cases of subclinical infection and stealth infection of the psoriatic mite, and the indirect ELISA method (rPsoSP 3-iELISA) using the recombinant serine protease inhibitor 3 has been reported to have the best diagnostic effect in serological diagnostic methods. Although the rpsop 3-iiisa can be used for early diagnosis of subclinical cases and cases of stealth infection by detecting specific IgG, the detection method cannot distinguish between an existing infection and a present infection due to the long period of IgG antibody regression.
Therefore, there is a need for a method for diagnosing pruritic mite, which has high sensitivity, high accuracy, and low operator requirements, and can discriminate the past infection from the present infection of pruritic mite.
Disclosure of Invention
Recently, molecular diagnostic methods based on PCR technology are used for detecting infection of parasites, viruses and bacteria, and research reports about the molecular marker gene of the itch mite in the prior art are mainly used for evaluating genetic studies of itch mite populations with different geographical sources and host sources, and the research reports about the molecular diagnostic method of the itch mite disease are not seen at present. In order to more efficiently diagnose the itch mite disease, the invention provides a PCR kit for diagnosing the itch mite disease and a PCR detection method for the itch mite disease of non-diagnosis purposes.
In a first aspect, the invention provides an application of ITS2, 16S, 12S and COX1 gene sequences of prunychus urticae in preparing a kit for diagnosing prunychus urticae.
Preferably, the gene sequence is ITS2, 12S.
Most preferably, the gene sequence is ITS2.
In a second aspect, the present invention provides a PCR kit for diagnosing psoroptes, wherein the kit comprises a specific primer, wherein the specific primer can be specifically combined with the ITS2, and/or 12S, and/or 16S, and/or COX1 gene sequence of psoroptes;
wherein, the sequence of the specific primer aiming at the ITS2 gene is shown in SEQ ID NO. 1-SEQ ID NO. 2;
the specific primer sequence aiming at the 12S gene is shown as SEQ ID NO. 3-SEQ ID NO. 4;
the specific primer sequence aiming at the 16S gene is shown as SEQ ID NO. 5-SEQ ID NO. 6;
the sequence of the specific primer aiming at the COX1 gene is shown as SEQ ID NO. 7-SEQ ID NO. 8.
Preferably, the specific primer in the kit is a specific primer sequence aiming at the ITS2 gene and/or a specific primer sequence aiming at the 12S gene.
Most preferably, the specific primer in the kit is a specific primer sequence aiming at the ITS2 gene.
The kit also comprises conventional reagents in the DNA extraction process, and/or conventional reagents in the PCR amplification reaction, and/or conventional reagents for detecting PCR amplification products.
Preferably, the kit further comprises a negative control substance, and the negative control substance is normal saline.
In a third aspect, the invention provides a PCR detection method for non-diagnostic itch mite, which is characterized by comprising the following steps:
(1) Extracting DNA of a sample to be detected;
(2) Preparing a PCR reaction system, which specifically comprises the following steps:
composition (A) | Volume of |
2×Taq PCR Master Mix | 5μL |
Specific primer | 0.25-1μL |
Template DNA | 0.5μL |
Ultrapure water | 3.5-4.25μL |
In total | 10μL |
(3) PCR amplification was performed, the procedure was as follows: performing 25-35 cycles of pre-denaturation at 95 deg.C for 3min, denaturation at 95 deg.C for 30s, annealing at 50-64 deg.C for 45s, and extension at 72 deg.C for 30s, maintaining at 72 deg.C for 5min, and storing at 4 deg.C;
(4) The PCR product was subjected to gel electrophoresis.
Preferably, the specific primer is added in a volume of 1. Mu.L in the step (2), and the upstream primer and the downstream primer are each added in a volume of 0.5. Mu.L.
Preferably, the PCR amplification procedure in step (3) is: pre-denaturing at 95 deg.C for 3min, denaturing at 95 deg.C for 30s, annealing at 50 deg.C, 60 deg.C, and 64 deg.C, performing 25 cycles at 45s and extension at 72 deg.C for 30s, maintaining at 72 deg.C for 5min, and storing at 4 deg.C.
The sample in the step (1) is a dry swab taken from an animal to be detected, wherein the animal to be detected comprises domestic animals and wild animals. Method for collection of dry swabs: repeatedly wiping the ear pit of the animal to be detected for 3-5 times by using a cotton swab, putting the cotton swab into a centrifugal tube, and storing at-20 ℃.
The technical scheme provided by the invention has the following advantages:
1. the invention provides a thought for designing specific primers aiming at ITS2, 16S, 12S and COX1 gene sequences of prurus armeniaca to prepare a qualitative PCR kit or a fluorescent quantitative PCR kit, and the inventor designs and screens experiments to prove that the specific primers designed aiming at ITS2 and 12S genes have good specificity, and further, the sensitivity of the specific primers aiming at ITS2 is higher and can reach 40.3 pg/mu L (20 times of DNA dilution of 1 mite).
2. The qualitative PCR kit for diagnosing the psoriatic acariasis and the method for carrying out PCR detection on the psoriatic acariasis by using the kit have higher detection sensitivity than microscopic examination, can discover early infected animals more comprehensively and earlier, have higher sensitivity and specificity, can be used for diagnosing subclinical cases and invisible infected cases with low-load parasitic infection, provide better guarantee for disease prevention and control, and can distinguish the existing infection from the existing infection.
Drawings
FIG. 1 12S, 16S, ITS2, COX1 gene PCR amplification, from left to right lane D2000DNA marker;12S;16S; ITS2; COX1; and (5) negative control.
FIG. 2 12S and ITS2 and 16S genes, D2000DNA marker from left to right; itch mite DNA; scabies mite DNA; rabbit skin tissue DNA; and (5) negative control.
FIG. 3 shows the sensitivity test of ITS2 and 12S genes, D2000DNA marker is shown in the left and right lanes; DNA of 10 itch mites; DNA of 5 itch mites; 1 itch mite DNA;1, diluting the DNA of the itch mite 1: 10; 1 itch mite DNA1:20 dilution; 1 itch mite DNA1:40 dilution; 1, diluting the DNA of the itch mite 1: 80; 1 itch mite DNA1:100 dilution; and (5) negative control.
FIG. 4 shows the optimization of PCR amplification procedure for ITS2 gene, D2000DNA marker in the left and right lanes; 25 circulation; 30 cycles; 35, circulating; negative control; d2000DNA marker;0.25 μ L;0.5 mu L;1 mu L of the solution; negative control; d2000DNA marker;50 ℃;55 ℃;60 ℃;65 ℃; and (5) negative control.
FIG. 5 comparison of diagnostic methods of microscopy, ELISA, PCR.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are only some embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Primer design
ITS2, 12S, 16S, COX gene sequences of p.ovis were downloaded from GeneBank, primers were designed using Primer Premier 5.0 software, specificity was confirmed using Primer blast for the designed primers, and primers were designed for ITS2, 12S, 16S, COX gene sequences as follows:
PCR detection method for psoroptes
S1: taking off the crust in the external auditory canal of the itch mite disease breeding rabbit by using tweezers, putting the scurf into a culture dish, putting the culture dish in a 37 ℃ incubator for 30min, collecting the worm bodies which climb out from the scurf, putting the collected mites in a 1.5mL EP tube for preservation at the temperature of minus 20 ℃ after morphological identification and confirmation, and extracting the DNA of the itch mites according to the instruction of an OMEGA micro-genome DNA extraction kit (Chengdu Baisbobo biotechnology Co., ltd.);
s2: adding 0.5 mu L of each specific primer, 0.5 mu L of template DNA, 5 mu L of 2 XTaq PCR Master Mix and 3.5 mu L of ultrapure water into a PCR reaction tube, wherein the total amount is 10 mu L, and oscillating by using a vortex instrument to fully Mix the primers; here, 4 PCR reaction systems are set, and specific primers are (1) 0.5. Mu.L of SEQ ID NO:1+ 0.5. Mu.L of SEQ ID NO:2, (2) 0.5. Mu.L of SEQ ID NO:3+ 0.5. Mu.L of SEQ ID NO:4, (3) 0.5. Mu.L of SEQ ID NO:5+ 0.5. Mu.L of SEQ ID NO:6, (4) 0.5. Mu.L of SEQ ID NO:7+ 0.5. Mu.L of SEQ ID NO:8;
s3: PCR amplification is carried out by taking prurus DNA as a template, and the program is as follows:
ITS2 amplification conditions: performing 25 cycles of pre-denaturation at 95 deg.C for 3min, denaturation at 95 deg.C for 30s, annealing at 50 deg.C for 45s, and extension at 72 deg.C for 30s, maintaining at 72 deg.C for 5min, and storing at 4 deg.C;
12S amplification conditions: pre-denaturation at 95 deg.C for 3min, denaturation at 95 deg.C for 30s, annealing at 60 deg.C for 45s, and extension at 72 deg.C for 30s for 25 cycles, maintaining at 72 deg.C for 5min, and storing at 4 deg.C;
16S amplification conditions: performing 25 cycles of pre-denaturation at 95 ℃ for 3min, denaturation at 95 ℃ for 30s, annealing at 64 ℃ for 45s and extension at 72 ℃ for 30s, finally keeping at 72 ℃ for 5min, and storing at 4 ℃;
COX1 amplification conditions: performing 25 cycles of pre-denaturation at 95 ℃ for 3min, denaturation at 95 ℃ for 30s, annealing at 64 ℃ for 45s and extension at 72 ℃ for 30s, finally keeping at 72 ℃ for 5min, and storing at 4 ℃; (ii) a
S4: an appropriate amount of the PCR amplification product was added to a gel block loading well containing a nucleic acid dye at an agarose concentration of 1.5% for electrophoresis, and observed using a gel imaging system, and the results are shown in FIG. 1.
The specific primers designed aiming at ITS2, 12S and 16S successfully amplify DNA extracted from the itch mite body through PCR, and the bands of PCR amplification products in gel are consistent with the expected sizes, so that the successful design of the ITS2, 12S and 16S primers is proved, but two bands are amplified by the COX1 specific binding primers and are not suitable for serving as diagnostic molecular targets.
Specificity test of primers
S1: extracting itch mite DNA, scabies mite DNA and rabbit skin tissue DNA according to the instruction of an OMEGA minigenome DNA extraction kit (Chengdabangsbuba biotechnology limited), wherein the scabies mite and rabbit ear skin tissue are provided by the research center of parasitic diseases of Sichuan agriculture university;
s2: adding 0.5 mu L of each specific primer, 0.5 mu L of template DNA, 5 mu L of 2 XTaq PCR Master Mix and 3.5 mu L of ultrapure water into a PCR reaction tube, wherein the total amount is 10 mu L, and oscillating by using a vortex instrument to fully Mix the primers; a total of 4 PCR reaction systems are set, and the specific primers are (1) ' 0.5 μ L SEQ ID NO:1+0.5 μ L SEQ ID NO:2, (2) ' 0.5 μ L SEQ ID NO:3+0.5 μ L SEQ ID NO:4, (3) ' 0.5 μ L SEQ ID NO:5+0.5 μ L SEQ ID NO:6;
s3: respectively taking itch mite DNA, scabies mite DNA and rabbit skin tissue DNA as templates to carry out PCR amplification, and the procedure is as follows:
ITS2 amplification conditions: performing 25 cycles of pre-denaturation at 95 deg.C for 3min, denaturation at 95 deg.C for 30s, annealing at 50 deg.C for 45s, and extension at 72 deg.C for 30s, maintaining at 72 deg.C for 5min, and storing at 4 deg.C;
12S amplification conditions: pre-denaturation at 95 deg.C for 3min, denaturation at 95 deg.C for 30s, annealing at 60 deg.C for 45s, and extension at 72 deg.C for 30s for 25 cycles, maintaining at 72 deg.C for 5min, and storing at 4 deg.C;
16S amplification conditions: performing 25 cycles of pre-denaturation at 95 ℃ for 3min, denaturation at 95 ℃ for 30s, annealing at 64 ℃ for 45s and extension at 72 ℃ for 30s, finally keeping at 72 ℃ for 5min, and storing at 4 ℃;
s4: an appropriate amount of the PCR amplification product was added to a gel block loading well containing a nucleic acid dye at an agarose concentration of 1.5% for electrophoresis, and observed using a gel imaging system, and the results are shown in FIG. 2.
No amplification products of ITS2 and 12S genes are detected in DNA of the sarcoptidosis and rabbit skin tissue samples, but 16S amplification products appear after the DNA of the rabbit skin tissue samples is amplified. PCR result analysis shows that the specificity of the primers of ITS2 and 12S is better, and the cross reaction (false positive) of the itch mite with the DNA of scabies mite and rabbit skin tissue samples can not occur.
Sensitivity testing of primers
S1: extracting prurus DNA according to the instruction of the OMEGA minigenome DNA extraction kit (venter baisbane biotechnology limited), setting the DNA concentration gradient: extracting DNA of 10 itch mites, 5 itch mites and 1 itch mite, and diluting the DNA of 1 itch mite into a sequence of 1;
s2: adding 0.5 mul of each specific upstream primer and downstream primer, 0.5 mul of template DNA, 5 mul of 2 XTaq PCR Master Mix and 3.5 mul of ultrapure water into a PCR reaction tube, wherein the total amount is 10 mul, and fully and uniformly mixing the primers by using a vortex instrument; 2 PCR reaction systems are arranged in total, and specific primers are respectively (1) 0.5 mu L SEQ ID NO:1+0.5 mu L SEQ ID NO:2, (2) 0.5 mu L SEQ ID NO:3+0.5 mu L SEQ ID NO:4;
s3: PCR amplification is carried out by taking the DNA of the prurus armeniaca with different concentrations set in the S1 as templates respectively, and the program is as follows:
ITS2 amplification conditions: performing 25 cycles of pre-denaturation at 95 deg.C for 3min, denaturation at 95 deg.C for 30s, annealing at 50 deg.C for 45s, and extension at 72 deg.C for 30s, maintaining at 72 deg.C for 5min, and storing at 4 deg.C;
12S: amplification conditions: pre-denaturation at 95 deg.C for 3min, denaturation at 95 deg.C for 30s, annealing at 60 deg.C for 45s, and extension at 72 deg.C for 30s for 25 cycles, maintaining at 72 deg.C for 5min, and storing at 4 deg.C;
s4: an appropriate amount of the PCR amplification product was added to a gel loading well containing a nucleic acid dye at an agarose concentration of 1.5% for electrophoresis, and the gel imaging system was used for observation, and the results are shown in FIG. 3.
Comparing the band brightness under 8 different DNA concentrations after electrophoresis, the result shows that the 12S specific primer can reach the sensitivity (0.403 ng/. Mu.L) of diluting the DNA of 1 itch mite by 10 times, while the ITS2 specific primer has high sensitivity to diluting the DNA of 1 itch mite by 20 times (40.3 pg/. Mu.L), so the ITS2 is more suitable for being used as a molecular target to carry out PCR diagnosis, and then the ITS2 purpose band gel is sent to sequence to be compared with the itch mite ITS2 sequence reported in a Genebank database, and the similarity between the sequence obtained by amplification and a reference sequence is 98.9%.
Optimization of PCR amplification procedure
Several factors that generally have a large impact on the PCR results are primer concentration, cycle number and annealing temperature, respectively, and this experiment optimizes these parameters.
The PCR detection method comprises the following steps:
s1: extracting prurus DNA according to the instruction of the OMEGA minigenome DNA extraction kit (chengdabangsbuba biotechnology limited);
s2: adding specific primers ITS2-F + ITS2-R, template DNA 0.5 muL, 2 XTaq PCR Master Mix 5 muL and ultrapure water 3.5-4.25 muL into a PCR reaction tube, wherein the total volume is 10 muL, and oscillating by using a vortex instrument to fully and uniformly Mix the primers;
s3: carrying out PCR amplification by using prurus armeniaca DNA as a template, wherein the program comprises the following steps: pre-denaturation at 95 ℃ for 3min, denaturation at 95 ℃ for 30s, annealing at 45s, extension at 72 ℃ for 30s, performing a certain number of cycles, keeping at 72 ℃ for 5min, and storing at 4 ℃;
s4: an appropriate amount of the PCR amplification product was added to a gel block loading well containing a nucleic acid dye at an agarose concentration of 1.5% for electrophoresis, and observed using a gel imaging system, and the results are shown in FIG. 4.
The variables are set as follows:
1. the primers in the PCR reaction system are respectively 0.25 muL, 0.5 muL and 1 muL;
2. cycling from denaturation to extension, wherein the number of cycles is set to 25 times, 30 times and 35 times respectively;
3. the annealing temperatures were 50 ℃, 55 ℃ and 60 ℃.
The PCR program was optimized by the above variables, and it was determined that the optimal cycle number was 25, the optimal annealing temperature was 50 ℃ and the optimal primer volume was 1. Mu.L.
PCR detection method, microscopic examination and ELISA comparison
1. Establishment of New Zealand rabbit itch mite disease artificial infection model and sample collection
Taking off the scab skin in the auditory meatus of the sick rabbit by using tweezers, putting the skin scraps into a culture dish, placing the culture dish in a 37 ℃ incubator for 2-3h, collecting the itch mite in the skin scraps, subpackaging 100 itch mite bodies into a 1.5mL centrifuge tube, and collecting enough itch mite bodies according to the amount of 100 infected itch mite bodies in one rabbit ear.
Rabbits to be infected (n = 9) were kept and their ear canals were plugged with cotton. And directly pouring the collected prurus armeniaca into ear pits of rabbit ears, sealing the ears with 5 x 7cm of medical dressing, and leaving a small part of gaps. The lower part of the rabbit ear is wound by using an adhesive tape (ensuring the blood circulation of the rabbit ear to be normal), and then an Elizabeth ring is worn on the rabbit to prevent the rabbit from scratching. Observing the rabbit after artificial infection, releasing the adhesive plaster after 24h, taking out the dressing and the plug after 2 days, taking off the Elizabeth ring after 3 days, and waiting for the rabbit to continuously infect the itch mite. Rabbits were treated with the drug 6 weeks post-infection and weighed to be injected subcutaneously with ivermectin in an amount of 0.1mL/kg.w, only once.
And (4) extracting a sample to be tested, including collection of a dry swab and serum.
And (3) collecting dry swabs, namely repeatedly wiping the infected 9 rabbits at the ear pits of the rabbits for 3-5 times by using a cotton swab after the infected 9 rabbits are well preserved, putting the cotton swab into a centrifugal tube, collecting 2 samples in total, marking the tube wall, storing 1 sample at normal temperature for traditional microscope detection, and storing the other 1 sample at-20 ℃ for PCR detection.
Collecting serum, collecting 3mL blood from ear vein of 9 infected rabbits, placing in 37 deg.C incubator for 30min, placing in 4 deg.C refrigerator for 3h, centrifuging supernatant and centrifuge tube at 3000g for 10min, and storing at-20 deg.C for ELISA detection.
The sampling time was 1, 2, 4, 6 weeks after infection and 3, 7, 11 days after treatment.
2. PCR detection
Extracting DNA of the collected dry swab by using an OMEGA micro-genome DNA extraction kit, detecting the stored dry swab DNA by using an optimized and established PCR method, and judging that a strip with an expected size is positive after gel electrophoresis.
3. Conventional microscopy
Placing the dry swab sample preserved at normal temperature into a culture dish, placing the culture dish in a 37 ℃ incubator for 30min, taking out the dry swab sample, placing the dry swab sample into a large glass plate, and cushioning the large glass plate on white paper, picking the live insect body on a glass slide, observing the live insect body by using a microscope, and judging the shape of the obvious itch mite body to be positive.
4. Detection of rPsoSP3-iELISA
The collected serum is detected by an rPsoSP3-iELISA method screened at the earlier stage of a subject group, and the basic steps are to take a 96-well enzyme label plate for antigen coating, dilute the rPsoSP3 to 35.5 mu g/mL by using a coating buffer solution, add 100 mu L of sample to each well of the 96-well plate, and coat overnight at 4 ℃. After overnight, the wells were rinsed by draining the liquid, washing each well with 200. Mu.L PBST, and washing with shaking. After completion, 300. Mu.L of blocking solution was added to each well and incubated at 37 ℃ for 1-2h. After washing, 100. Mu.L of the serum to be tested diluted with PBS to 1:40 was added to each well and incubated at 37 ℃ for 1 hour. After washing, 100. Mu.L of HRP-labeled sheep anti-rabbit IgG antibody (1 10000) diluted in PBS was added to each well, and incubated at 37 ℃ for 1h. And finally washing for color development, adding 100 mu L of TMB color development liquid into each concave hole, and standing for 20min in a dark place. Adding 100 μ L of stop solution, and measuring OD450 with enzyme-labeled color developing instrument, wherein the result is positive when cut-off value exceeds 0.401, and the result is negative otherwise.
All rabbits in this trial were successfully infected with prurus mites, and samples taken at 1, 2, 4, 6 weeks of infection and 3, 7, 11 days after treatment were examined by conventional microscopy, PCR and iELISA, with results shown in FIG. 5.
At week 1, the traditional microscopy revealed only 33.3% (3/9) of positive rates, reaching 100% (9/9) at week 2. The positive rates of the microscopic examination were reduced to 66.6% (6/9) and 11.1% (1/9) at 3 days after the treatment and 7 days after the treatment, respectively, and the positivity at 7 days after the treatment was due to the microscopic examination of the dead and dead bodies in the ear of rabbit No. 9.
The positivity of the iELISA at week 1 was 77.7% (7/9), and the OD450 values were greater than cut-off value 0.401 from week 2 to day 11 after treatment, and were generally stable after rising.
As a result of the PCR diagnosis, the positive rate reached 88.9% (8/9) at week 1 and 100% (9/9) at week 2. The positive rates of 3 days after treatment and 7 days after treatment are 66.6% and 0% respectively, but the condition of yang recovery of No. 8 rabbit is found on 11 days after treatment, but the condition of yang recovery is not detected by microscopic examination and iELISA, and a small amount of dead insect bodies or debris may remain in No. 8 rabbit after treatment, so that the residual itch mite bodies or debris can not be collected every time when the dry swab is sampled, and subsequent yang recovery is caused, therefore, the sampling of the dry swab can be carried out for multiple times, and then the dry swab is mixed for PCR, so that the detection sensitivity is improved.
By combining the experimental result, the positive detection rate of the 1 st week PCR detection method is 88.9 percent and is obviously higher than the detection rate of 33.3 percent of microscopic examination, which shows that the PCR detection sensitivity is higher than that of microscopic examination in the diagnosis of the psoriatic acariasis, so that early infected rabbits can be discovered more early and more comprehensively, and a better guarantee is provided for the prevention and control of the psoriatic acariasis.
Compared with ELISA, PCR has similar sensitivity, but does not have complicated steps for preparing antigen protein, and has good specificity, thereby avoiding the occurrence of false positive, most importantly, due to the long-term existence of the antibody in the host body, the ELISA can not distinguish the existing infection from the existing infection, and the PCR can make up for the defect.
Practical application of PCR in rabbit farm
36 dry swab samples collected from a rabbit field with a history of the scrapie epidemic disease are subjected to traditional microscope and PCR detection, wherein 4 positive samples are detected by a microscope, the detection rate is 11.1%, the PCR detection of the 4 positive samples is positive, but 2 positive samples are detected by 2 negative samples, 6 positive samples are detected in the 36 samples, the detection rate is 16.7%, and the results are shown in the following table.
TABLE 1
Finally, it should be noted that: the above embodiments are only used to illustrate the technical solution of the present invention, and not to limit the same; while the invention has been described in detail and with reference to the foregoing embodiments, it will be understood by those skilled in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some or all of the technical features may be equivalently replaced; and the modifications or the substitutions do not make the essence of the corresponding technical solutions depart from the scope of the technical solutions of the embodiments of the present invention.
Claims (10)
1. The application of ITS2, 16S, 12S and COX1 gene sequences of the itch mite in preparing a kit for diagnosing the itch mite disease.
2. The use according to claim 1, wherein the gene sequence is ITS2, 12S.
3. The use according to claim 1, wherein the gene sequence is ITS2.
4. A PCR kit for diagnosing itch mite disease, wherein said kit comprises a specific primer, said specific primer can be specifically combined with ITS2, and/or 12S, and/or 16S, and/or COX1 gene sequence of itch mite;
wherein, the sequence of the specific primer aiming at the ITS2 gene is shown in SEQ ID NO. 1-SEQ ID NO. 2;
the specific primer sequence aiming at the 12S gene is shown as SEQ ID NO. 3-SEQ ID NO. 4;
the sequence of the specific primer aiming at the 16S gene is shown as SEQ ID NO. 5-SEQ ID NO. 6;
the sequence of the specific primer aiming at the COX1 gene is shown as SEQ ID NO. 7-SEQ ID NO. 8.
5. The kit according to claim 4, wherein the specific primer in the kit is a specific primer sequence for ITS2 gene and/or a specific primer sequence for 12S gene.
6. The kit according to claim 5, wherein the specific primer in the kit is a specific primer sequence for ITS2 gene.
7. The kit according to claim 4, wherein the kit further comprises conventional reagents used in DNA extraction process, and/or conventional reagents used in PCR amplification reaction, and/or conventional reagents used in detection of PCR amplification product.
8. A PCR detection method for non-diagnostic itch mite is characterized by comprising the following steps:
(1) Extracting DNA of a sample to be detected;
(2) Preparing a PCR reaction system, which specifically comprises the following steps:
(3) PCR amplification was performed, the procedure was as follows: performing 25-35 cycles of pre-denaturation at 95 deg.C for 3min, denaturation at 95 deg.C for 30s, annealing at 50-64 deg.C for 45s, and extension at 72 deg.C for 30s, maintaining at 72 deg.C for 5min, and storing at 4 deg.C;
(4) The PCR product was subjected to gel electrophoresis.
9. The detection method according to claim 8, wherein the specific primer is added in a volume of 1. Mu.L in the step (2), and the upstream primer and the downstream primer are each added in a volume of 0.5. Mu.L.
10. The detection method according to claim 8, wherein the PCR amplification procedure in step (3) is as follows: pre-denaturing at 95 deg.C for 3min, denaturing at 95 deg.C for 30s, annealing at 50 deg.C, 60 deg.C, and 64 deg.C, performing 25 cycles at 45s and extension at 72 deg.C for 30s, maintaining at 72 deg.C for 5min, and storing at 4 deg.C.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210856989.0A CN115725742B (en) | 2022-07-20 | 2022-07-20 | PCR (polymerase chain reaction) kit for diagnosing itch mite disease and detection method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210856989.0A CN115725742B (en) | 2022-07-20 | 2022-07-20 | PCR (polymerase chain reaction) kit for diagnosing itch mite disease and detection method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115725742A true CN115725742A (en) | 2023-03-03 |
CN115725742B CN115725742B (en) | 2024-03-26 |
Family
ID=85292616
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210856989.0A Active CN115725742B (en) | 2022-07-20 | 2022-07-20 | PCR (polymerase chain reaction) kit for diagnosing itch mite disease and detection method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115725742B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201017705D0 (en) * | 2010-10-20 | 2010-12-01 | Moredun Res Inst | Mite detection |
CN107478835A (en) * | 2017-08-09 | 2017-12-15 | 四川农业大学 | The application of itch mite protein tyrosine kinase and the kit for diagnosing psoroptic mange |
CN111965353A (en) * | 2020-08-18 | 2020-11-20 | 四川农业大学 | Application of scrapie ovis cathepsin L and ELISA kit |
-
2022
- 2022-07-20 CN CN202210856989.0A patent/CN115725742B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201017705D0 (en) * | 2010-10-20 | 2010-12-01 | Moredun Res Inst | Mite detection |
CN107478835A (en) * | 2017-08-09 | 2017-12-15 | 四川农业大学 | The application of itch mite protein tyrosine kinase and the kit for diagnosing psoroptic mange |
CN111965353A (en) * | 2020-08-18 | 2020-11-20 | 四川农业大学 | Application of scrapie ovis cathepsin L and ELISA kit |
Non-Patent Citations (2)
Title |
---|
X.B. GU等: "Development of the first PCR for detection of Psoroptes ovis var. cuniculi infection and its comparison to microscopic examination and serological assay in rabbits", VETERINARY PARASITOLOGY, 28 June 2023 (2023-06-28), pages 109979 * |
李燕方等: "基于线粒体12S基因全序列分析 我国绵羊痒螨(兔亚种)的遗传多样性基于线粒体12S基因全序列分析 我国绵羊痒螨(兔亚种)的遗传多样性", 畜牧兽医学报, vol. 49, no. 11, 31 December 2018 (2018-12-31), pages 2468 - 2476 * |
Also Published As
Publication number | Publication date |
---|---|
CN115725742B (en) | 2024-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Weiss et al. | Molecular biology, molecular phylogeny, and molecular diagnostic approaches to the microsporidia | |
CN108384899B (en) | Fluorescent quantitative PCR kit for detecting novel goose astrovirus and application thereof | |
CN112662787B (en) | PCR primer, kit and method for poultry sex identification | |
CN103725796A (en) | BVDV (bovine viral diarrhea virus) internal control typing fluorescent PCR (polymerase chain reaction) detection kit and preparation thereof | |
CN107354219B (en) | Method and kit for identifying penguin sex | |
CN104651534A (en) | Porcine circovivus loop-mediated isothermal amplification kit and application thereof | |
CN108048603A (en) | A kind of K subgroup avian leucosis virus detection kit | |
Ahmadivand et al. | Cyprinid herpesvirus 3 (CyHV-3) transmission and outbreaks in Iran: Detection and characterization in farmed common carp | |
Teixeira et al. | Detection of turkey coronavirus in commercial turkey poults in Brazil | |
CN101368179B (en) | Reagent kit for extracting DNA in Chinese alligator chorion film and use method thereof | |
CN101575649B (en) | Quick detection technology for H9 type avian influenza virus | |
CN108531660A (en) | A kind of 3 type real-time quantitative LAMP primer of detection pig circular ring virus, kit and application | |
CN110093446B (en) | Primer and probe combination for detecting phytophthora cinnamomi by recombinase-mediated isothermal amplification-lateral flow chromatography technology and application of primer and probe combination | |
CN115725742A (en) | PCR kit for diagnosing psoroptes and detection method | |
KR101767644B1 (en) | Composition and method for prediction of pigs litter size using gene expression profile | |
CN100363502C (en) | Spiroplasma pathogenic microorganism PCR fast checking technique | |
CN105256071A (en) | Method for quickly detecting carp herpes virus type III | |
CN116064826A (en) | Primer and method for detecting bovine-derived DNA | |
CN115927651A (en) | Primer and method for detecting swine-origin DNA | |
CN106521038A (en) | High-sensitivity BHV-2 (bovine herpes virus 2) quantitative real-time PCR (polymerase chain reaction) detection method and kit | |
CN106435012A (en) | Real-time fluorescent PCR (polymerase chain reaction) kit for detecting swing Isospora in piglet umbilical cord blood and application thereof | |
CN106282399A (en) | The PCR detection primer of a kind of Borrelia burgdoyferi and detection method | |
CN106755299B (en) | Primer pair and method for comparing intestinal tract immune development ability of weaned piglets | |
Magang et al. | Prevalence of blood and skin trypanosomes in domestic and wild fauna from two sleeping sickness foci in Southern Cameroon | |
CN105821160A (en) | Reverse transcription loop-mediated isothermal amplification (RT-LAMP) kit for porcine kobuvirus and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |